About Proventra Company Information Scientific Information Investor Relations GalaGen News
 
What's New!

First Quarter 2001 Financial Results


New Shareholder Newsletter
The Year 2000 in Review

GalaGen Signs Term Sheet for New Financing

Up to $10 million of preferred stock and related warrants to be placed with private investors.

The Wall Street Transcript Interviews GalaGen CEO
Henry Cardello describes GalaGen's colostrum technology "platform" and what's in store for 2001.

     PDF version    Download an
Acrobat Reader

CEOCast.com Interviews Cardello
To hear the audio version click here.

New Investor Relations Section Adds
In-Depth Data To Web Site

Click here for current stock price, charts and comprehensive analytical summaries.

"Our aim is to inform investors of material developments at GalaGen as quickly as possible. The new interactive section provides relevant financial data and the ability to directly communicate with us. We invite you to give it a closer look."
— Frank Kuhar, Chief Financial Officer
Top  |  Home